Browse Tag Heres

Here’s How Much Warren Buffett Has Made on Wells Fargo

Warren Buffett’s track record as an investor and CEO is unmatched. In his 54 years running Berkshire Hathaway (NYSE: BRK-A)(NYSE: BRK-B), thousands of people have become millionaires by buying shares and then sitting on their hands while he turned the former textile manufacturer into one of the most-profitable holding companies on Earth. As of this writing, Berkshire […]

Read more

Here’s Why Coeur Mining Stock Fell as Much as 17.5% Today

What happened Shares of Coeur Mining (NYSE: CDE) fell over 17% today after the company reported preliminary fourth-quarter and full-year 2019 operating results. The precious metals miner delivered solid performance from three mines: Palmarejo (the best-performing asset in the portfolio), Kensington (a 12% year-over-year increase in gold output), and Wharf (10% year-over-year increase in gold […]

Read more

Here’s Why Mirati Therapeutics Jumped 28% in December

What happened Shares of Mirati Therapeutics (NASDAQ: MRTX), a clinical-stage biopharmaceutical company, rose 27.9% in December, according to data from S&P Global Market Intelligence. Investors were revved up by results from an ovarian cancer study involving Mirati’s sitravatinib plus tislelizumab, an anti-PD1 antibody from BeiGene (NASDAQ: BGNE). So what  Most of the attention directed at Mirati Therapeutics […]

Read more

Here’s Why You Should Add SolarEdge Technologies Stock Now

SolarEdge Technologies, Inc. SEDG is expected to benefit from strong financial position and expertise in module shipment. As of Sep 30, 2019, the company has shipped approximately 45.4 million power optimizers and 1.9 million inverters. Also, SolarEdge Technologies has shipped approximately 14.6 GW of DC optimized inverter systems. Let’s focus on the factors that make […]

Read more

Here’s Why DURECT Jumped Higher Today

What happened Shares of DURECT (NASDAQ: DRRX) are up 8% at 11:54 a.m. EST, having increased as much as 12% today, as investors jump in ahead of a Food and Drug Administration advisory committee meeting to review its pain drug Posimir scheduled for release Jan. 16. So what The original marketing application for Posimir was […]

Read more

If You Had Invested $100 in McDonald’s IPO, Here’s How Much Money You’d Have Now

The stock market has returned a respectable 2,700% since 1965, the year that McDonald’s (NYSE: MCD) filed its initial public offering, or IPO. Shareholders lucky enough to get in early on that fantastic business have been rewarded for that prescience and that long-term holding period. In fact, even a relatively small investment in the fast-food […]

Read more